Philips Revises Use Instructions for BiPAPs Due to Risk of Therapy Loss
Philips Respironics updated the use instructions for BiPAP V30, A30, and A40 ventilators due to potential therapy interruptions and serious health risks.
Philips Respironics updated the use instructions for BiPAP V30, A30, and A40 ventilators due to potential therapy interruptions and serious health risks.
Amid a massive recall in 2021, the medical device maker Philips raced to overcome troubling questions about its replacement machines as customers waited for help.
Philips Respironics has paid $2,471,359.25 to resolve allegations that it violated the False Claims Act by giving kickbacks to sleep laboratories, according to the U.S. Attorney’s Office for the Southern District of California.
Read More“With Every Breath,” a new documentary from ProPublica and the Pittsburgh Post-Gazette, is an intimate glimpse into what happens when patients and a doctor learn that a lifesaving device may be causing harm.
Read MoreFollowing warnings that CPAP masks with magnetic closures may interfere with certain medical devices and implants, sleep physicians have questions. Here’s what to know.
Read MorePhilips raised its 2023 earnings outlook following an uptick in third-quarter sales, despite ongoing challenges related to its CPAP and ventilator device recall.
Read MoreUS Senator Dick Durbin and US Representative Jan Schakowsky have introduced legislation to reform medical device recalls in an effort to improve patient safety.
Read MoreSen. Richard Blumenthal is calling for “immediate, aggressive action” against Philips for keeping known defects with the company’s CPAP machines secret.
Read MorePhilips Respironics says it plans to conduct additional testing on certain CPAP and respiratory devices involved in its June 2021 recall at the request of the FDA.
Read MoreProPublica and the Pittsburgh Post-Gazette have filed suit against the US Food and Drug Administration, accusing the agency of holding back records related to the recall of breathing machines.
Read MoreA look at answers to some of the most critical questions about the ongoing recall of millions of CPAP machines, ventilators, and other breathing devices.
Read MoreTo understand the breakdowns that led to one of the most tumultuous medical device recalls in generations, ProPublica and the Pittsburgh Post-Gazette spent a year probing what happened inside Philips Respironics after the company first learned that contaminants were turning up in breathing machines designed to save lives.
Read MoreExor NV, a Netherlands-based diversified holding company, has bought a 15% stake in Royal Philips, with an option to increase it to 20%.
Read MorePhilips Respironics provided the latest results and conclusions on the comprehensive test and research program to assess potential health risks related to the polyester-based polyurethane sound abatement foam in specific sleep therapy and ventilator devices under the voluntary June 2021 recall.
Read MorePhilips Respironics provided an update on the field action for specific sleep therapy and ventilator devices involved in the company’s ongoing recall.
Read MoreThe FDA updated its Philips Respironics recall safety communication to provide updated information about medical device reports that the agency received from Jan 1 to March 31.
Read MoreThe national consortium of law firms will advance the carriage of a class action related to the recall of Philips’ CPAP and ventilator devices.
Read More